Try our Advanced Search for more refined results
TEVA PHARMACEUTICALS USA, INC. v. AMGEN INC.
Case Number:
2:09-cv-05675
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 15, 2011
Amgen, Teva Settle Patent Suit Over Neopogen Generic
A Pennsylvania federal judge on Friday approved a settlement between generics maker Teva Pharmaceuticals USA Inc. and Amgen Inc. that squashes Teva's hopes of marketing a copycat version of the blood drug Neopogen until 2013.
-
November 22, 2010
Amgen Loses Bid To Wrap Up Teva Patent Fight
Pharmaceutical giant Amgen Inc. has lost its bid for partial summary judgment in a patent spat launched by Teva Pharmaceuticals USA Inc. as part of its effort to market a generic version of Amgen's blood drug Neupogen.